ARCHIVES

NCI Closes Iressa Trial For NSCLC When Data Indicate No Survival Benefit

This article is from The Cancer Letter archive.

Vol. 28 No. 4 | April 29, 2005

Download PDF Visit The Full Archive

Related Articles

Pfizer Begins Phase III Trial Of Sunitinib In NSCLC

September 28, 2007

75% Of Fed Research Funds Pay Direct Costs, Study Says.

July 28, 2000

Bipartisan Deal Eases Some Budget Cuts By Extending Sequestration Through 2023

December 13, 2013

ACS Professors; Connie Mack Is Chairman Of Moffitt Board.

February 9, 2001

NCI 1985 Bypass Budget By Groups

May 20, 1983

House Committee Begins Investigation Of NCI’s National Lung Screening Trial.

October 26, 2007